Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShort-Term Debt repayments
Ratios

bioAffinity Technologies (BIAF) Depreciation & Amortization (IS) (2022 - 2025)

Historic Depreciation & Amortization (IS) for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $113360.0.

  • bioAffinity Technologies' Depreciation & Amortization (IS) fell 2507.5% to $113360.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $534809.0, marking a year-over-year decrease of 1098.27%. This contributed to the annual value of $605637.0 for FY2024, which is 14265.08% up from last year.
  • Latest data reveals that bioAffinity Technologies reported Depreciation & Amortization (IS) of $113360.0 as of Q3 2025, which was down 2507.5% from $113229.0 recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Depreciation & Amortization (IS) high stood at $154588.0 for Q1 2025, and its period low was $773.0 during Q3 2022.
  • Its 4-year average for Depreciation & Amortization (IS) is $95731.5, with a median of $113360.0 in 2025.
  • Per our database at Business Quant, bioAffinity Technologies' Depreciation & Amortization (IS) soared by 734747.74% in 2023 and then tumbled by 2507.5% in 2025.
  • Quarter analysis of 4 years shows bioAffinity Technologies' Depreciation & Amortization (IS) stood at $7330.0 in 2022, then skyrocketed by 1929.84% to $148787.0 in 2023, then rose by 3.26% to $153632.0 in 2024, then fell by 26.21% to $113360.0 in 2025.
  • Its Depreciation & Amortization (IS) stands at $113360.0 for Q3 2025, versus $113229.0 for Q2 2025 and $154588.0 for Q1 2025.